Jabil Confirms Q3 Outlook; Withdraws FY25 Outlook; Appoints Michael Dastoor CEO, Gregory Hebard CFO

RTTNews | 178 days ago
Jabil Confirms Q3 Outlook; Withdraws FY25 Outlook; Appoints Michael Dastoor CEO, Gregory Hebard CFO

(RTTNews) - Jabil Inc. (JBL) announced Monday it is confirming the previously provided third-quarter guidance for net revenue of $6.2 billion to $6.8 billion, earnings of $0.82 to $1.38 per share and core earnings of $1.65 to $2.05 per share.

On average, eight analysts polled by Thomson Reuters expected the company to report earnings of $2.21 per share on revenues of $6.83 billion for the third quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2025, the the Company is withdrawing its previously provided guidance, given the current visibility in certain end markets, along with the unanticipated CEO transition.

Separately, Jabil announced the appointment of Michael Dastoor, who has been serving as Chief Financial Officer and Interim CEO, as Chief Executive Officer. He succeeds Kenneth Wilson, who will no longer serve as Chief Executive Officer or on Jabil's Board of Directors.

Gregory Hebard, most recently Senior Vice President, Treasurer, has been appointed Chief Financial Officer.

These actions follow the completion of the investigation related to corporate policies, which Jabil initially disclosed on April 18, 2024.

read more
Jabil Guides Q3 In Line With Estimates; Q2 Results Top Estimates

Jabil Guides Q3 In Line With Estimates; Q2 Results Top Estimates

While reporting preliminary, unaudited financial results for its second quarter on Thursday, Jabil Inc. (JBL) said it expects third-quarter earnings in a range of $1.50 to $1.90 per share and core earnings in a range of $1.70 to $2.10 per share on net revenues between $7.9 billion and $8.5 billion.
RTTNews | 609 days ago
Jabil Again Boosts FY22 Outlook - Update

Jabil Again Boosts FY22 Outlook - Update

While reporting preliminary, unaudited financial results for the third quarter on Thursday, Jabil Inc. (JBL) raised its core earnings and revenue guidance for the full-year 2022, based on solid demand in key areas of its business. The company also provided financial outlook for the fourth quarter.
RTTNews | 882 days ago
FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the treatment of aromatic L-amino acid decarboxylase or AADC deficiency. Kebilidi is the first FDA-approved gene therapy for the deficiency. PTC shares gained around 8.5 percent in the extended trading on the Nasdaq on Thursday.
RTTNews | 5h 30min ago
Asian Markets Mostly Higher

Asian Markets Mostly Higher

Asian stock markets are trading mostly higher on Friday, despite the broadly negative cues from Wall Street overnight, as traders react to a bunch of upbeat economic data from the region, including upbeat GDP data from Japan. Regional gains remained very modest after the U.S. Fed said it would slash interest rates carefully amid inflation pressures. Asian markets ended mixed on Thursday.
RTTNews | 7h 47min ago
China Industrial Output Rises 5.3% On Year In October

China Industrial Output Rises 5.3% On Year In October

Industrial production in China was up 5.3 percent on year in October, the National Bureau of Statistics said on Friday - slowing from 5.4 percent in September and missing expectations for 5.5 percent.
RTTNews | 8h 59min ago
Japanese Market Significantly Higher

Japanese Market Significantly Higher

Snapping a three-session losing streak, the Japanese stock market is significantly higher on Friday, despite the broadly negative cues from Wall Street overnight. The benchmark Nikkei 225 is moving well above the 38,800 level, with gains across all sectors led by index heavyweights and technology stocks as traders reacted to solid domestic GDP data.
RTTNews | 9h 1min ago